Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumours

Grattan-Smith, P J; Morris, J G; Langlands, A O
October 1992
Journal of Neurology, Neurosurgery & Psychiatry;Oct1992, Vol. 55 Issue 10, p949
Academic Journal
journal article
No abstract available.


Related Articles

  • Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. Evans, D. G. R.; Birch, J. M.; Ramsden, R. I.; Sharif, S.; Baser, M. E. // Journal of Medical Genetics;Apr2006, Vol. 43 Issue 4, p289 

    In recent years the use of radiation treatment for benign tumours has increased with the advent of stereotactic delivery and, in particular, single high dose gamma knife therapy. This has been particularly true for benign CNS (central nervous system) tumours such as vestibular schwannoma,...

  • Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities. Alexiou, George A.; Tsiouris, Spyridon; Kyritsis, Athanasios P.; Voulgaris, Spyridon; Argyropoulou, Maria I.; Fotopoulos, Andreas D. // Journal of Neuro-Oncology;Oct2009, Vol. 95 Issue 1, p1 

    Treatment for brain gliomas is a combined approach of surgery, radiation therapy and chemotherapy. Nevertheless, high-grade gliomas usually recur despite treatment. Ionizing radiation therapy to the central nervous system may cause post-radiation damage. Differentiation between post-irradiation...

  • Atypical tentorial meningioma 30 years after radiotherapy for a pituitary adenoma. Santoro, A.; Minniti, G.; Paolini, S.; Passacantilli, E.; Missori, P.; Frati, A.; Cantore, G. P. // Neurological Sciences;Mar2002, Vol. 22 Issue 6, p463 

    Although the human central nervous system used to be considered relatively resistant to the carcinogenic action of ionizing radiation, several lines of evidence now document a high incidence of secondary tumors in irradiated patients. The numerous reports of radiation-induced cerebral...

  • Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-κB. Taoufik, Era; Tseveleki, Vivian; Chu, Seung Y.; Tselios, Theodore; Karin, Michael; Lassmann, Hans; Szymkowski, David E.; Probert, Lesley // Brain: A Journal of Neurology;Sep2011, Vol. 134 Issue 9, p2722 

    Tumour necrosis factor mediates chronic inflammatory pathologies including those affecting the central nervous system, but non-selective tumour necrosis factor inhibitors exacerbate multiple sclerosis. In addition, TNF receptor SF1A, which encodes one of the tumour necrosis factor receptors, has...

  • Central nervous system irradiation: toxicity, limitations. Plieskiene, A.; Dauksas, T.; Andrijaitiene, V.; Burdulis, D. // Medical Physics in the Baltic States;2012, p1 

    The article presents several slideshows on toxicity and limitations on irradiation of the central nervous system, including radiation injury to the nervous system, the techniques for stereotactic cranial irradiation and the damage of hippocampal neurogenesis.

  • Pituitary tumour pathogenesis. Heaney, Anthony P. // British Medical Bulletin;Dec2005, Vol. 75/76 Issue 1, p81 

    Pituitary adenomas are the most common tumours in the central nervous system, make up approximately 10% of all primary intracerebral tumours [1] and are found incidentally in 3–27% of autopsies [2]. The predisposition to tumour formation of the highly specialized cellular phenotypes that...

  • Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis. Jun Liang; Fan Wang; Dandan Wang; Huayong Zhang; Cheng Zhao; Shiying Wang; Lingyun Sun // Stem Cell Research & Therapy;11/4/2015, Vol. 6, p1 

    Radiation myelitis is a rather rare but devastating complication following therapeutic irradiation to neoplasms when the spinal cord is included within the radiation field. Symptoms of radiation myelitis with the therapeutic doses of radiation commonly employed are usually delayed and most often...

  • Craniopharyngioma. Garnett, Matthew R.; Puget, Stéphanie; Grill, Jacques; Sainte-Rose, Christian // Orphanet Journal of Rare Diseases;2007, Vol. 2, p18 

    Craniopharyngiomas are benign slow growing tumours that are located within the sellar and para sellar region of the central nervous system. The point prevalence of this tumour is approximately 2/100,000. The onset of symptoms is normally insidious with most patients at diagnosis having...

  • Predictive Risk of Radiation Induced Cerebral Necrosis in Pediatric Brain Cancer Patients after VMAT Versus Proton Therapy. Freund, Derek; Rui Zhang; Sanders, Mary; Newhauser, Wayne // Cancers;2015, Vol. 7 Issue 2, p617 

    Cancer of the brain and central nervous system (CNS) is the second most common of all pediatric cancers. Treatment of many of these cancers includes radiation therapy of which radiation induced cerebral necrosis (RICN) can be a severe and potentially devastating side effect. Risk factors for...

  • Dependence of the Risk of Encephalopathy on the Radiotherapy Volume after Combined Surgery and Radiotherapy of Invasive Pituitary Tumours. Rauhut, F.; Stuschke, M.; Sack, H.; Stolke, D. // Acta Neurochirurgica;Jan2002, Vol. 144 Issue 1, p37 

    Summary The effectiveness of radiotherapy in reducing tumour recurrence of pituitary adenomas is well documented. On the other hand, the risk of side effects to the surrounding central nervous system normal tissue should not be underestimated. This retrospective study includes 58 patients with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics